SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-019161
Filing Date
2017-03-24
Accepted
2017-03-24 16:13:03
Documents
3
Period of Report
2017-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-8508_38k.htm 8-K 23566
2 EX-99.1 a17-8508_3ex99d1.htm EX-99.1 143892
3 GRAPHIC g85083mm01i001.jpg GRAPHIC 2821
  Complete submission text file 0001104659-17-019161.txt   172571
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 17712901
SIC: 2834 Pharmaceutical Preparations